In order to confront the COVID-19 crisis, we need to immediately mobilize global scientific and technical talent. We have refreshed our Request for Startups, which are concepts we believe are important in the coming decades, to reflect this newest addition: Responding to COVID-19.
Mar 25, 2020Ginkgo Bioworks was the first bio company YC funded, back in summer 2014, which makes us especially delighted to announce a new partnership between YC and Ginkgo. Ginkgo…
Sep 16, 2019I’ve noticed that raising money for a biotech or other life science company in 2019 looks a lot like raising money for a tech company 10 years ago. Since then, fundamental forces caused fundraising for tech companies to change dramatically. And I believe that they are going to change biotech fundraising very much the way they changed tech company fundraising.
Aug 5, 2019We’re going to work with Atomwise to give interested Artificial Intelligence Molecular Screen (AIMS) teams an expedited path to joining YC.
Apr 29, 2019YC started funding bio companies in 2011 and since then the number of bio companies we’ve funded per batch has risen exponentially, now over 141 in total. To support our growing number of bio companies, we are hiring a Visiting Partner to work with them.
Nov 12, 2018Over the last two years, YC has made more seed investments in bio companies than any other investor in the world. The number of bio companies in each batch has been exponentially increasing, and there are now 141 bio companies funded by YC.
Sep 11, 2018
David Zeevi is a James S. McDonnell independent fellow at the Rockefeller University Center for Studies in Physics and Biology. He focuses on developing computational methods for studying microbial ecology in the human gut and in the marine environment, and its contribution to human and environmental health. He was one of the authors on the paper Personalized Nutrition by Prediction of Glycemic Responses.
Aug 22, 2018